General Information of Drug (ID: DMLYUEO)

Drug Name
MBN-101
Indication
Disease Entry ICD 11 Status REF
Diabetic foot ulcer BD54 Phase 2 [1]
Cross-matching ID
PubChem CID
10327332
TTD ID
D0UC5G

References

1 ClinicalTrials.gov (NCT02436876) Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites. U.S. National Institutes of Health.